GO:0016593 Cdc73/Paf1 complex: Components & Methods

The Cdc73/Paf1 complex (GO:0016593) is a conserved, RNA polymerase II-associated multiprotein assembly that was originally identified in Saccharomyces cerevisiae as a novel polymerase II-containing complex distinct from the Srb-containing holoenzyme. It is now recognized as a general transcription elongation factor that travels with elongating RNA polymerase II and coordinates multiple co-transcriptional processes, including histone modification and RNA processing. Because it sits at the interface between transcription and RNA maturation, the complex is a focal point for understanding how gene expression is regulated at a genome-wide level. Research on the PAF1 complex has expanded from yeast genetics into metazoan development and human disease. In zebrafish, PAF1 complex subunits differentially regulate cardiomyocyte specification, demonstrating that the complex is not merely a housekeeping elongation factor but can influence cell-fate decisions. In human neurons, the PAF1 complex is required for transcription of toxic expanded GGGGCC repeats in C9orf72-associated frontotemporal dementia, providing a direct mechanistic link between this transcription complex and neurodegeneration. In yeast, Paf1 and Ctr9 maintain low levels of telomeric repeat-containing RNA, connecting the complex to telomere biology and genome stability. For researchers, GO:0016593 provides a precise annotation for experiments that interrogate transcription elongation, co-transcriptional RNA processing, and the protein-protein interactions that assemble the complex. Understanding its composition, assembly and regulation is essential for designing loss-of-function, point-mutation and tagged knock-in models that can dissect its many functions.

GO:0016593 (Cdc73/Paf1 complex) is defined in the Gene Ontology as a multiprotein complex that associates with RNA polymerase II and general RNA polymerase II transcription factor complexes and may be involved in both transcriptional initiation and elongation. In Saccharomyces, the complex contains Paf1p, Cdc73p, Ctr9p, Rtf1p and Leo1p. The term is synonymous with the Paf1 complex and the Paf1p complex, and it is annotated as a cellular component.

The Cdc73/Paf1 complex is important because it couples transcription elongation by RNA polymerase II to co-transcriptional events that determine the fate of nascent RNA. Its association with polymerase II and general transcription factors places it at the center of gene-expression control, and its subunits are required for normal development and for preventing pathological transcription in disease contexts. Because the complex is conserved and its core subunits are essential for stability, it also serves as a tractable model for studying how multiprotein assemblies coordinate nucleic acid transactions.

The following genes and proteins are the principal components and functional partners of the Cdc73/Paf1 complex (GO:0016593) as reported in the verified literature.

The Cdc73/Paf1 complex is regulated at the level of subunit availability and complex integrity. In yeast, the core Paf1-Ctr9 submodule is required for maintaining low levels of telomeric repeat-containing RNA, indicating that loss of core subunits alters the functional output of the complex. Genetic interactions between PAF1 complex genes and ESCRT machinery genes further suggest that the complex is modulated by cellular trafficking pathways. In disease contexts, the complex is required for transcription of toxic expanded GGGGCC repeats, implying that its recruitment or activity at specific loci can be regulated by the underlying DNA sequence and associated factors.

Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated frontotemporal dementia, directly implicating GO:0016593 in the production of disease-causing repeat RNA. This finding suggests that interfering with PAF1 complex function could reduce toxic repeat transcription, making it a candidate therapeutic target.

The PAF1 complex differentially regulates cardiomyocyte specification, indicating that perturbations in complex function could affect heart development. This links GO:0016593 to developmental disorders of the heart and provides a model for studying tissue-specific transcriptional control.

Paf1 and Ctr9, core components of the PAF1 complex, maintain low levels of telomeric repeat-containing RNA, connecting the complex to telomere homeostasis. Dysregulation of this function could contribute to genome instability, although direct disease associations require further study.

The Cdc73/Paf1 complex was originally identified by biochemical purification of an RNA polymerase II-containing complex distinct from the Srb-containing holoenzyme. Modern affinity purification coupled to mass spectrometry can define subunit composition and stoichiometry in different cell types.

RNA-seq can measure the impact of PAF1 complex perturbation on global transcription and on specific RNA species such as telomeric repeat-containing RNA and toxic GGGGCC repeat RNA. These approaches reveal which genes and repeats depend on the complex.

Cis and trans genetic interactions between PAF1 complex genes and ESCRT machinery genes have been mapped in yeast, demonstrating the value of systematic genetic screens for uncovering pathways connected to GO:0016593.

In vertebrate models, the PAF1 complex differentially regulates cardiomyocyte specification, which can be studied using developmental imaging and marker analysis. Such assays link molecular function to tissue-level outcomes.

Researchers studying Cdc73/Paf1 complex-related genes often need to determine whether a candidate gene is causally involved in transcription elongation, co-transcriptional RNA processing, or disease-relevant repeat transcription. Rigorous causal testing requires well-controlled genetic models that isolate the function of individual subunits and their domains.

The Cdc73/Paf1 complex (GO:0016593) is a conserved RNA polymerase II-associated assembly that coordinates transcription elongation with co-transcriptional RNA processing. Its core subunits Paf1 and Ctr9 are required for maintaining low levels of telomeric repeat-containing RNA, and the complex is directly implicated in toxic repeat transcription in C9orf72-associated frontotemporal dementia and in cardiomyocyte specification. Understanding its composition, assembly and regulation provides a foundation for mechanistic studies and for therapeutic strategies targeting repeat-expansion diseases.